Etodolac Extended Release Tablets USP 600mg

DRUG2 trials

Sponsors

IPCA Laboratories Ltd.

Conditions

Fasting

Phase 1

Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fasting Condition

CompletedNCT01827865

IPCA Laboratories Ltd.Fasting

Start: 2012-11-30End: 2012-11-30Updated: 2013-04-10

Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed Condition

CompletedNCT01831687

IPCA Laboratories Ltd.Fasting

Start: 2012-12-31End: 2013-01-31Updated: 2013-04-15